Joke Bilcke

12PUBLICATIONS
31CO-AUTHORS
Agro-ecosystem function and predictionCross-sectional analysisInfant and child healthEpidemiological methodsSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 25, 2026
Cost-Effective Threshold Price for Alternative Infant and Neonatal Rotavirus Vaccines: A Dual-Country Evaluation.

|Jul 29, 2024
Cost per episode of diarrhea and respiratory syncytial virus (RSV) in 128 low- and middle-income countries: how well do disease-specific and WHO-CHOICE estimates align?

Xiao Li, Joke Bilcke, Ernest O Asare

|Jul 17, 2023
The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach.

Marina Antillón, Xiao Li, Lander Willem

|Sep 27, 2022
Authors' Reply to Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine".

Joke Bilcke, Philippe Beutels

|Sep 21, 2022
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries.

Xiao Li, Joke Bilcke, Alike W van der Velden

|Jan 30, 2022
Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine.

Zoë Pieters, Benson Ogunjimi, Philippe Beutels

Pageof 2

Frequent Collaborators

8 joint publications

Philippe Beutels

5 joint publications

Xiao Li

2 joint publications

Alike W van der Velden

2 joint publications

Emily Bongard